InMode Ltd. is rated a Strong Buy due to its robust balance sheet, proprietary technology, and international growth. Learn more about INMD stock here.

*Please refer to "Use of Non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided ...

InMode Ltd. (NASDAQ:INMD) Q4 2025 Earnings Call Transcript February 10, 2026 InMode Ltd. beats earnings expectations.

InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies ("InMode" or the "Company"), today issued the following statement: ...

InMode Ltd. (NASDAQ:INMD) reported fourth-quarter earnings and revenue on Tuesday that came in ahead of expectations, but its weaker-than-anticipated guidance for 2026 weighed on investor sentiment.

Good day, and welcome to the InMode fourth quarter and full year 2024 earnings results conference call. [Operator instructions] Please note, this event is being recorded. I would now like to turn the ...

InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will host investor meetings at the BTIG MedTech, ...

Despite a year-over-year revenue decline, InMode Ltd (INMD) sees promising growth in international sales and prepares for new product launches in 2026.

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...

Good day, and welcome to InMode's second quarter 2024 earnings results conference call. All participants will be in listen-only mode. [Operator instructions]. After today's presentation, there will be ...

The MarketWatch News Department was not involved in the creation of this content. YOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative ...

Thank you, Miri, and to everyone for joining us. With me today are Dr. Michael Crindel, our Co-Founder and Chief Technology Officer, Yair Malca, our Chief Financial Officer, and Rafael Liqueman, our ...